Grace Therapeutics, Inc. Current Ratio in % from Q4 2020 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Grace Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q4 2020 to Q3 2025.
Grace Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 971 %, a 2.98% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Grace Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	971	-29.8	-2.98%	Sep 30, 2025
Q2 2025	801	-544	-40.4%	Jun 30, 2025
Q1 2025	775	-741	-48.9%	Mar 31, 2025
Q4 2024	811	-461	-36.2%	Dec 31, 2024
Q3 2024	1K	-128	-11.3%	Sep 30, 2024
Q2 2024	1.34K	+363	+37%	Jun 30, 2024
Q1 2024	1.52K	+531	+53.9%	Mar 31, 2024
Q4 2023	1.27K	+163	+14.7%	Dec 31, 2023
Q3 2023	1.13K	-137	-10.8%	Sep 30, 2023
Q2 2023	982	-344	-25.9%	Jun 30, 2023
Q1 2023	985	-627	-38.9%	Mar 31, 2023
Q4 2022	1.11K	-895	-44.7%	Dec 31, 2022
Q3 2022	1.27K	-683	-35%	Sep 30, 2022
Q2 2022	1.33K	-354	-21.1%	Jun 30, 2022
Q1 2022	1.61K	+725	+81.7%	Mar 31, 2022
Q4 2021	2K	+1.61K	+408%	Dec 31, 2021
Q3 2021	1.95K			Sep 30, 2021
Q2 2021	1.68K			Jun 30, 2021
Q1 2021	887			Mar 31, 2021
Q4 2020	394			Dec 31, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.